Latest

​边界与流动:全球公民身份大会迎来 20 周年

Tuesday, 03 Nov 2026 4:11PM

苏黎世, Nov 3 (Bernama-GLOBE NEWSWIRE) -- 随着各国政府争相吸引国际资本、企业家å...

See More
Cambridge International AS & A Level June Series Results to Be Released Earlier From 2027

Tuesday, 03 Nov 2026 3:44PM

June series Cambridge International AS & A Level results moved two weeks earlierGives internatio...

See More

Other Press Release

虽十月市场低迷,Bitget 保护基金仍维持 7.41 亿美元平均值

Wednesday, 10 Dec 2025 9:13AM

塞舌尔维多利亚, Dec 10 (Bernama-GLOBE NEWSWIRE) -- 全球最大的全景交易所 (UEX) ...

See More
EBC Financial Group 荣获 2025 年度专业交易者大奖“最佳执行经纪商”奖项

Wednesday, 10 Dec 2025 9:12AM

该奖项由专业及活跃交易者投票选出,凸显了执行质量在机构级交易中的关é...

See More
Pink Changing Lives®: Mary Kay Builds 11th Preschool in Sri Lanka, Turning a Dream Into Thousands of New Beginnings

Tuesday, 09 Dec 2025 11:43AM

Mary Kay Inc., a global champion for women’s empowerment, is turning pink into purpose through...

See More
Post-Merger Taishin Securities Investment Trust Rises to Top Ten, Aims for NT$1 Trillion AUM

Tuesday, 09 Dec 2025 11:40AM

Taishin Financial Holding Co. and Shin Kong Financial Holding Co. completed their merger on November...

See More
Toshiba Releases 40V Electronic Fuses (eFuse ICs) for Industrial and Consumer Applications

Tuesday, 09 Dec 2025 11:22AM

<a href="nteprimages/20251209_790035.jpg" target="_blank"><img border=&...

See More
​Helical Fusion Signs Japan’s First Power Purchase Agreement for Fusion Energy with Aoki Super

Tuesday, 09 Dec 2025 11:03AM

Takaya Taguchi (left), CEO of Helical Fusion Co., Ltd. , and Masayuki Kono (right) Managing Director...

See More
​Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy

Tuesday, 09 Dec 2025 10:55AM

RICHARDSON, Texas, Dec 9 (Bernama-GLOBE NEWSWIRE) -- Mavenir, the software company building AI-by-de...

See More
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

Tuesday, 09 Dec 2025 10:53AM

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductio...

See More